Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Strong founder effect of p.P240L in CDH23 in Koreans and its significant contribution to severe-to-profound nonsyndromic hearing loss in a Korean pediatric population

Fig. 1

A diagnostic flow chart of the enrolled subjects. Of a total of 438 subjects with various onset and degree of sensorineural hearing loss (SNHL) diagnosed from 2010 to 2014 at SNUH or SNUBH, 128 with the prelingual onset of a severe-to-profound degree of hearing loss, and with an autosomal recessive (AR) or sporadic hereditary pattern were included in this study. The 310 subjects either with pre-lingual mild to moderate degree SNHL or with post-lingual SNHL subjects are excluded from the present study. SLC26A4 and/or GJB2 were sequenced, and the p.P240L of CDH23 was screened in subjects without SLC26A4 or GJB2 mutations. One of the subjects (SB166-208) with post-lingual SNHL identified to carry p.P240L of CDH23 is included in the STR marker genotyping analysis. Next, targeted resequencing (TRS) of the 80Ë—204 known deafness genes was performed. Asterisks indicates MYO15A compound heterozygotes; SB77-133, SH10-28, SHJ23, dagger indicates MYO7A compound heterozygotes; SH156-272, SH91-202, SB71-123. Control group I (272 subjects) was assigned for p.P240L mutation screening and control group II (40 subjects) was assigned for STR genotyping. All control groups showed normal hearing.

Back to article page